eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


3/2020
vol. 7
 
Share:
Share:
more
 
 
abstract:
Review paper

Vaccine against COVID-19 or against SARS-CoV-2 infection?

Piotr Rieske
1, 2

1.
Zakład Biologii Nowotworów, Uniwersytet Medyczny w Łodzi
2.
Celther Polska
Alergologia Polska – Polish Journal of Allergology 2020; 7, 3: 131–145
Online publish date: 2020/08/05
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Article offers analysis of main aspects of SARS-CoV-2/COVID-19 vaccination (severe acute respiratory syndrome coronavirus 2/COVID-19-Coronavirus Disease 2019). Optimal vaccine should protect not only against disease COVID-19 (symptoms), but also against SARS-CoV-2 infection (spreading disease). However, this kind of vaccine – showing highest safety level is extremely difficult to get. Several additional SARS-CoV-2/COVID-19 vaccination issues were addressed in article. For example: serological passports, herd immunity, clinical trials, and role of antibodies and T cells crossreactivities. Article discusses some issues related to vaccination responsibilities.
keywords:

SARS-CoV-2, vaccine, COVID-19

Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe